Company Profile
ProPhase Labs Stock Price, News & Analysis
- Ticker:
- PRPH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.05 USD (+5.07%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, PRPH closed up 5.07% at $0.0460. No new same-company headline was identified in the current news window.
Company overview
Business overview
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, ProPhase sits in consumer health and diagnostics.
Business Model Characteristics
The company depends on product and test adoption, commercial execution, and the ability to monetize a small portfolio of assets.
Position Within the Biotechnology Landscape
ProPhase is outside biotech proper and belongs to the consumer-diagnostics and health-products layer.
Future catalysts
ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction. Investors will care about whether the business can find a stable growth path.
Recent news
- 01
- 02
- 03
- 04
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
Source: ProPhase Labs
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of ProPhase Labs (PRPH)?
ProPhase Labs (PRPH) most recently closed at 0.05 USD, a +5.07% move versus the previous session.
What does ProPhase Labs do?
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
On which exchange is PRPH stock listed?
ProPhase Labs (PRPH) is associated with NASDAQ, United States, Biopharma.
What is ProPhase?
ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction.
Which conditions is ProPhase Labs targeting with ProPhase?
ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction.
How does ProPhase Labs describe recent progress with ProPhase?
ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction.
What is Labs?
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products.
What should investors watch for with Labs?
ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction.